ITC Asks for Comments on ResMed's Breathing Treatment Devices Patent Complaint

The International Trade Commission is asking for comments by Aug. 2 on public interest factors raised by ResMed’s Section 337 patent complaint on sleep-disordered breathing treatment devices. The July 19 complaint is ResMed’s second in the span of three months on the devices, which are used in the treatment of obstructive sleep apnea by delivering pressurized air to the user to keep that user’s breathing passages open during sleep (see 13072308). This one alleges violations by BMC Medical of China and its U.S. affiliates 3B Medical and 3B Products. ResMed is requesting limited exclusion and cease and desist orders barring imports by the companies.